Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4594905 | 1.00 | TRPA1 (0.33) | TRPA1TRPM8 | |
| SCHEMBL4595650 | 0.84 | LMNA (0.32) | — | |
| SCHEMBL2349957 | 0.81 | SLC1A2 (0.31) | — | |
| SCHEMBL21300577 | 0.80 | TRPA1 (0.38) | TRPA1TRPM8 | |
| SCHEMBL121847 | 0.77 | USP2 (0.32) | — | |
| SCHEMBL2363468 | 0.77 | USP2 (0.32) | — | |
| SCHEMBL375500 | 0.77 | USP2 (0.32) | — | |
| SCHEMBL555559 | 0.75 | TRPA1 (0.34) | TRPA1TRPM8 | |
| SCHEMBL4594903 | 0.75 | TRPA1 (0.33) | TRPA1TRPM8 | |
| SCHEMBL29145813 | 0.75 | TRPA1 (0.33) | TRPA1TRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 862 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220331344-A1 | ORAL FORMULATIONS OF PSYCHOTROPIC MACROFUNGUS BOTANICAL EXTRACTS WITH MOUTHFEEL EXPERIENCE ENHANCERS | CHICAGO ATLANTIC ADMIN, LLC | 2022-10-20 | — | — | US | claimed |
| US-20210212983-A1 | ORAL CANNABINOID DELIVERY FORMULATIONS WITH MOUTHFEEL EXPERIENCE ENHANCERS | CHICAGO ATLANTIC ADMIN, LLC | 2021-07-15 | — | — | US | claimed |
| US-20190037896-A1 | COOLING FORMULATIONS | WM. WRIGLEY JR. COMPANY (US) | 2019-02-07 | — | — | US | claimed |
| EP-3355710-A2 | COOLING FORMULATIONS | Wm. Wrigley Jr. Company (US) | 2018-08-08 | — | — | EP | claimed |
| CN-108135214-A | Cool taste preparation | WM.雷格利 JR.公司 | 2018-06-08 | — | — | CN | claimed |
| EP-1924148-B1 | CONFECTIONERY COMPOSITION INCLUDING AN ELASTOMERIC COMPONENT, A COOKED SACCHARIDE COMPONENT, AND A SENSATE | INTERCONTINENTAL GREAT BRANDS LLC (US) | 2016-07-20 | — | — | EP | claimed |
| CN-103732060-B | Antimicrobial compositions | TAKASAGO INTERNATIONAL CORP. (JP) | 2016-02-17 | — | — | CN | claimed |
| EP-1534252-B1 | BREATH FRESHENING AND ORAL CLEANSING PRODUCT USING CARDAMOM OIL | WRIGLEY W M JUN CO (US) | 2010-06-30 | — | — | EP | claimed |
| EP-2001448-A2 | FLAVOR-ENHANCING COMPOSITIONS, METHODS OF MANUFACTURE, AND METHODS OF USE | Cadbury Adams USA LLC (US) | 2008-12-17 | — | — | EP | claimed |
| WO-2007089652-A2 | FLAVOR-ENHANCING COMPOSITIONS, METHODS OF MANUFACTURE, AND METHODS OF USE | CADBURY ADAMS USA LLC (US) | 2007-08-09 | — | — | WO | claimed |
| US-20040141927-A1 | Chewing gums, confections, mouthwashes, mouth sprays and edible thin film products | WM. WRIGLEY JR. COMPANY | 2004-07-22 | — | — | US | claimed |
| WO-2004045590-A1 | ORAL PRODUCTS CONTAINING NOVEL FLAVOR COMPOSITION | WM. WRIGLEY JR. COMPANY (US) | 2004-06-03 | — | — | WO | claimed |
| WO-2004019800-A2 | BREATH FRESHENING AND ORAL CLEANSING PRODUCT | WM. WRIGLEY JR. COMPANY (US) | 2004-03-11 | — | — | WO | claimed |
| WO-2004019867-A2 | BREATH FRESHENING AND ORAL CLEANSING PRODUCT USING CARDAMOM OIL | WM. WRIGLEY JR. COMPANY (US) | 2004-03-11 | — | — | WO | claimed |
| WO-2004019922-A1 | BREATH FRESHENING AND ORAL CLEANSING PRODUCT USING CITRAL | WM. WRIGLEY JR. COMPANY (US) | 2004-03-11 | — | — | WO | claimed |
| WO-2004019870-A2 | BREATH FRESHENING AND ORAL CLEANSING PRODUCT USING SALICYLALDEHYDE | WM. WRIGLEY JR. COMPANY (US) | 2004-03-11 | — | — | WO | claimed |
| WO-2004019802-A2 | BREATH FRESHENING AND ORAL CLEANSING PRODUCT USING CARVACROL | WM. WRIGLEY JR. COMPANY (US) | 2004-03-11 | — | — | WO | claimed |
| WO-2004019871-A2 | BREATH FRESHENING AND ORAL CLEANSING PRODUCT USING GERANIOL | WM. WRIGLEY JR. COMPANY (US) | 2004-03-11 | — | — | WO | claimed |
| US-20030072842-A1 | Chewing gum having prolonged sensory benefits | WM. WRIGLEY JR. COMPANY | 2003-04-17 | — | — | US | claimed |
| WO-2002091849-A1 | A CHEWING GUM HAVING PROLONGED SENSORY BENEFITS | WM. WRIGLEY JR. COMPANY (US) | 2002-11-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220331344-A1 | ORAL FORMULATIONS OF PSYCHOTROPIC MACROFUNGUS BOTANICAL EXTRACTS WITH MOUTHFEEL EXPERIENCE ENHANCERS | MB, MLEC, NISCH | TRPA1 2103/4885TRPM8 1381/4885 |
| US-20190037896-A1 | COOLING FORMULATIONS | TAS2R30, MGLL, TAS2R60 | TRPA1 305/4885TRPM8 83/4885 |
| US-20210212983-A1 | ORAL CANNABINOID DELIVERY FORMULATIONS WITH MOUTHFEEL EXPERIENCE ENHANCERS | CNR2, CNR1, CPNE4 | TRPA1 339/4885TRPM8 46/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.